drug
pegfilgrastim
Marketedupdated 3mo agoby Accord Biopharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval10 co-mentions · 5 sources
- drugSTIMUFEND8 co-mentions · 4 sources
- companyFresenius Kabi USA LLC4 co-mentions · 4 sources
- drugRNS-604 co-mentions · 4 sources
- companyAccord Biopharma Inc2 co-mentions · 1 sources
- tagRecall2 co-mentions · 1 sources
- drugARMLUPEG2 co-mentions · 1 sources
- companyLupin Ltd1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying pegfilgrastim
- phase2ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- phase2Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- phase2Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
- phase2Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- phase2Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
- phase1Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
- phase2Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
- phase2Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that